James DArecca - 11 Apr 2022 Form 3 Insider Report for HAEMONETICS CORP (HAE)

Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. D'Arecca
Issuer symbol
HAE
Transactions as of
11 Apr 2022
Net transactions value
$0
Form type
3
Filing time
14 Apr 2022, 16:29:28 UTC
Previous filing
12 Aug 2021
Next filing
04 May 2022

No securities are beneficially owned.

Remarks:

On April 5, 2022, the Compensation Committee of the Board of Directors of the Issuer approved an equity grant for the Reporting Person valued at $600,000. The grant consists of 50% restricted stock units and 50% non-qualified stock options that will each vest in annual increments of 25% beginning on the first anniversary of the date of grant of May 2, 2022, which is the first business day of the month following the Reporting Person's start date. The exact number of restricted stock units issued and the strike price of the stock options will be based upon the closing price of the Company's common stock on the grant date, and the exact number of stock options issued will be determined using the applicable Black-Scholes value, and will be reported on a Form 4 following the grant date.